Rubicon Research IPO: Pharmaceutical company Rubicon Research completed its anchor investor round on Wednesday, 8 October 2025. The firm raised ₹619 crore from the anchor investors ahead of its initial public offering (IPO).
(This is a developing story. Please check back for updates)
Read all stories by Anubhav Mukherjee
Disclaimer: This story is for educational purposes only. The views and recommendations above are those of individual analysts or broking companies, not Mint. We advise investors to check with certified experts before making any investment decisions.
